SARS-CoV-2
Showing NaN - NaN of 10
SARS-CoV-2 Trial in United States (mRNA-1273.214, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273.214
- Placebo
-
Madera, California
- +21 more
Jan 11, 2023
SARS-CoV-2 Trial in United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Banning, California
- +48 more
Jan 5, 2023
Coronavirus Disease 2019 With Point-of-Care Ultrasonography
Completed
- Coronavirus Infection
- +3 more
- Point-of-Care Ultrasonography (POCUS)
-
Minneapolis, Minnesota
- +1 more
Jan 2, 2023
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
SARS-CoV-2 Trial in Canada, United States (mRNA-1273, Placebo)
Recruiting
- SARS-CoV-2
- mRNA-1273
- +2 more
-
Birmingham, Alabama
- +89 more
Oct 7, 2022
SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1283.211, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- mRNA-1283
- +3 more
-
Phoenix, Arizona
- +16 more
Sep 22, 2022
SARS-CoV-2 Trial in United States (mRNA-1273.214)
Recruiting
- SARS-CoV-2
- mRNA-1273.214
-
Montebello, California
- +6 more
Jul 28, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
-
Colorado Springs, Colorado
- +38 more
Mar 31, 2022
Detecting SARS-CoV-2 in Tears
Not yet recruiting
- COVID
- +3 more
- Tear Collection
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 21, 2022